Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far

Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far

Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk. On the basis of the favorable outcomes of recent randomized clinical trials conducted in intermediate and low risk popu...

Full description

Bibliographic Details
Main Authors: Fadi Sawaya, Troels H. Jørgensen, Lars Søndergaard, Ole De Backer
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
aortic valve replacement
transcatheter
valve dysfunction
valve deterioration
thrombosis
endocarditis
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2019.00145/full

Internet

https://www.frontiersin.org/article/10.3389/fcvm.2019.00145/full

Similar Items